Subject Areas : Report of Health Care

Heydar Aghababa ¹ ( Department of biology, Arsanjan Branch, Islamic Azad University, Arsanjan, Iran )
Sana Edalat Panah ² ( Department of biology, Arsanjan Branch, Islamic Azad University, Arsanjan, Iran )
Bahareh Jokar ³ ( Department of biology, Arsanjan Branch, Islamic Azad University, Arsanjan, Iran )

Received: 2018-07-14 Accepted : 2018-07-28 Published : 2017-12-01

Keywords:

References:

1. Ansari Sh. Williams obstetrics. 25 ed. Golban Medical Publication. 2018.

2. Zare Z, Meshkibaf MH, Hamaiatkhah V, Ranjbaran R, Takhshid MA. Positive correlation of resistinwith blood lipids in gestational diabetes. J Fums. 2013; 4: 330- 334.

3. Niyafar M, Salem A, Asgharzadeh AA. Risks factors for gestational diabetes and prevalence of impaired glucose tolerance six weeks after delivery. Tabriz Med Sci Univ J 2017; 39 (5): 73- 80.

4. Clause JO, Hensen T, Bjorbaek C, Echwald SM, Urhamer SA, Rasmussen S, et al. Insulin resistance interaction between obesity and a common variant ofinsulin receptor substrate-1. Lancet. 1995; 346: 397- 402.

5. Groop L, Lyssenko V. Genes and type 2 diabetes mellitus. Curr Diab Rep. 2008; 8 (3): 192- 197.

6. Baroudi Oiederni T, Sanchez-Corona J, Fadiel A, Jhonson-Scalise T, Beeghly-Fadiel A, Flores Martinez S, et al. Polymorphism study of the insulin receptor substrate IRS- 1 and IRS- 2 genes associated with type 2 diabetes in ethnic groups djirba island . Clin Med Revies. 2010; 2: 185- 190.

7. Buchanan TR, Xiang A, Kjos SL, Watanabe R. What is gestational diabetes?. Diabetes Care. 2007; 302: 105- 111.

8. Almind K, Bjorbaek C, Vestergaard H, Hansen T, Echwald S, Pedersen O. Amino- acid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet. 1996; 342 (8875): 828- 832.

9. Saravani R, Noorzehi N, Galavi HR, Ranjbar N, Lotfian sargazi M. Association of perilipin and IRS-1 genes polymorphism with lipid profiles, central obesity and type 2 diabetes in a sample of Iranian population. Iran Red Cres Med. 2017; 19 (6): 55- 63.

10. Cornelis MC, Hu FB. Gene-environment

interactions in the development of type 2 diabetes: recent progress and continuing challenges. Annu Rev Nutr. 2012; 32: 245- 259.

11. Sheikhha MH, Afkhami- Ardakani MR, Mirjalili MR, Dehghani MR, et al. Investigating the frequency of mspi polymorphism of APOA1 gene type 2 diabetic patients and comparing it with this frequency in non-diabetics. Genetics. 2013; 3: 3079- 3083.

12. Ghorbani M. A review of type 2 diabetes and obesity. Mol Cell Biot. 2015; 5 (18): 9- 14.

13. Hart LM, Stolk RP, Dekker JM, Nijpels G, Grobbee DE, Heine RJ. Prevalence of variants in candidate gene for type 2 diabetes mellitus. J Clin Endocrinol Metab. 1999; 84: 1002- 1006.

14. Arikoglu H, Askoy hepdogru M, Erkoc kaya D, Asik A, Hilmi ipekci S, Iscioglu F, et al. Irs-1 gene polymorphism Gly972 Arg and Ala513Pro are not associated with insulin resistance and type 2 diabetes risk in non- obese Turkish population. Meta Gene. 2014; 2: 579- 585.

15. Bodhini D, Radha V, Mohan V. Association study of IRS-1 gene polymorphism with type 2 diabetes in south Indians. Diabetes Technol Ther. 2011; 7: 767- 772.